Skip to content
Snippets Groups Projects
Commit d1ad0699 authored by Wenyi Guan's avatar Wenyi Guan
Browse files

Update file engineering.tsx

parent 4ef15dd2
No related branches found
No related tags found
No related merge requests found
Pipeline #505560 passed
......@@ -95,6 +95,10 @@ export function Engineering() {
<p>Since over-accumulated ammonia is one of the pathogenic factors of HE (see our Description page to learn more), we decided to design an ammonia-sensing module first. We envisioned our sensing module to specifically respond to the level of ammonia and could activate the downstream metabolic module to eliminate ammonia. </p>
<p>After literature research, we learned that most bio-sensors are based on transcriptional factor-inducible promoter systems [1]. However, we failed to find such an inducible promoter that can be activated by NH3 with high specificity. Therefore, we had to switch our design to sensing another risk factor of cirrhosis progression that may lead to HE.</p>
<h4>Redesign & Build</h4>
<p>During the next round of literature reading and brain storming, we learned that the level of bile acid decreases in cirrhosis patients and it was verified in some clinical studies[2-3], so we endeavored to seek systems that could respond to bile acids. Under the generous help and suggestions of Professor Zhu Bo (find more in our integrated human practice page), we found Martínez et al in 2019 developed bile acid inducible promoters in Lactobacillus strains[4]. </p>
<p>However, the level of bile acid is negatively related to the severity of cirrhosis, so we tried to utilize the "NOT" logic gate by introducing Cl/Plam genetic circuit. Plam is a potent promoter found in the lambda bacteriophage, while Cl is an inhibitory protein that can bind to the Plam promoter, thereby repressing downstream gene expression[5].</p>
<p>Next, we re-designed the sensing module as shown in Figure 2. The normal level of bile acid can activate the expression of pchA downstream of the inducible bile acid promoter, releasing transcriptional factor pchA to activate PLEE1 and express CL, which can inhibit Plam to express metabolic module. In contrast, when bile acid decreases in cirrhosis patients who are likely to develop HE, the inhibitory effect can be eliminated and thus initiate the expression of metabolic module to work.</p>
<h4>Test</h4>
<h4>Learn</h4>
<h3>Cycle 2: Construction of the Sensing Module</h3>
......
0% Loading or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment